X-GEN CAR T PLATFORM Trademark

Trademark Overview

On Thursday, February 18, 2021, a trademark application was filed for X-GEN CAR T PLATFORM with the United States Patent and Trademark Office. The USPTO has given the X-GEN CAR T PLATFORM trademark a serial number of 90533614. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by Tmunity Therapeutics, Inc.. The X-GEN CAR T PLATFORM trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, genetically engineered cells for immunotherapy purposes
x-gen car t platform

General Information

Serial Number90533614
Word MarkX-GEN CAR T PLATFORM
Filing DateThursday, February 18, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements

Goods and ServicesBiological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, genetically engineered cells for immunotherapy purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTmunity Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameTmunity Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Monday, February 22, 2021NEW APPLICATION ENTERED
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Thursday, November 4, 2021EXAMINERS AMENDMENT E-MAILED
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 4, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 4, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, November 4, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, November 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 6, 2022SOU EXTENSION 1 FILED
Wednesday, July 6, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2023SOU EXTENSION 3 FILED
Tuesday, January 17, 2023SOU EXTENSION 2 FILED
Tuesday, January 17, 2023SOU EXTENSION 2 GRANTED
Thursday, January 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2023SOU EXTENSION 3 GRANTED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU EXTENSION 4 FILED
Tuesday, January 9, 2024SOU EXTENSION 4 GRANTED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED

Related Keywords

platform cancer treatment therapy preparations genetically namely purposes engineered cells products